- FOLFIRI as Second-line Chemotherapy after Failure of FOLFOX4 in Advanced Colorectal Cancer: A Korean Single-center Experience
-
Kim JH, Park SJ, Park MI, Moon W, Kim SE, Ku KH, Song SE, Kim JH
- KMID: 1711301
- Korean J Gastroenterol.
- 2014 Jan;63(1):18-24.
- doi: 10.4166/kjg.2014.63.1.18
BACKGROUND/AIMS: The incidence of colorectal cancer has been increasing every year in Korea. Irinotecan- or oxaliplatin-based regimens including biologic agents are known to be effective in patients with advanced colorectal... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors for Metastatic Colorectal Cancer after First-line Chemotherapy with FOLFOX-4 or FOLFIRI Regimen
-
Kim JH, Choi PR, Park SJ, Park MI, Moon W, Kim SE, Lee GW
- KMID: 1791877
- Korean J Gastroenterol.
- 2014 Apr;63(4):209-215.
- doi: 10.4166/kjg.2014.63.4.209
BACKGROUND/AIMS: Information on prognostic factors for metastatic colorectal cancer is an important basis for planning the treatment and predicting the outcomes of the patients; however, it has not been well... -
- CITED
-
- Close
- SHARE
-
- Close
